COTI-2, a novel small molecule that is active against multiple human cancer cell lines<i>in vitro</i>and<i>in vivo</i>
Kowthar Y. Salim, James Koropatnick(Lawson Health Research Institute)
Cited by 152
Related Papers
CD5 blockade enhances ex vivo CD8 <sup>+</sup> T cell activation and tumour cell cytotoxicity
|European Journal of Immunology|2020|41